Vedang Murthy

Vedang Murthy: Is 25Gy/5 enough for prophylactic nodal RT in high-risk Prostate Cancer?

Vedang Murthy, Professor GU-Radiation Oncology at Tata Memorial Centre Mumbai, shared a post on X:

“With the new year, comes new insight.

Is 25Gy/5 enough for prophylactic nodal RT in high-risk Prostate Cancer?

Borrowed from rectal cancer protocols, it has never been validated for prostate SBRT—until now.

The SHARP consortium offers insights.”

Pelvic regional control with 25Gy in 5 fractions in SBRT for high risk prostate cancer: Pooled prospective outcomes from the SHARP consortium

Authors: Vedang Murthy, Indranil Mallick, Priyamvada Maitre, Gargee Mulye, Moses Arunsingh, Luca Valle, Michael Steinberg, Thomas Kennedy, Andrew Loblaw, Amar U Kishan.

Vedang Murthy

Amar U. Kishan Andrew Loblaw cancer Gargee Mulye Indranil Mallick Luca Valle Michael Steinberg Moses Arunsingh OncoDaily Oncology Priyamvada Maitre prostate cancer rectal cancer Thomas Kennedy Vedang Murthy